Acute liver failure associated with Fructus Psoraleae: a case report and literature review

• Main Authors: Ang Li, Minhong Gao, Na Zhao, Ping Li, Jinguo Zhu, Wenfei Li
• Format: Article
• Language: English
• Published: BMC 2019-04-01
• Series: BMC Complementary and Alternative Medicine
• Subjects: Fructus Psoraleae; Qubaibabuqi tablets; Vitiligo; Hepatotoxicity
• Online Access: http://link.springer.com/article/10.1186/s12906-019-2493-9

Abstract Background Fructus Psoraleae is the seed of Psoralea corylifolia Linn. Fructus Psoraleae has been shown to be effective in treating some skin diseases, such as vitiligo. As a main ingredient in five types of herbs in the Qubaibabuqi tablet formula, Fructus Psoraleae plays an important role in the treatment of vitiligo. Fructus Psoraleae has potential hepatotoxicity, thus Qubaibabuqi tablets also have potential liver toxicity. Case presentation A 53-year-old woman who was diagnosed with vitiligo in September 2017 was treated with Qubaibabuqi tablets. After approximately 7 months of treatment, the patient developed a severe, diffuse yellow staining of the skin and sclera in March 2018. On admission, she was diagnosed with acute cholestatic hepatitis associated with Fructus Psoraleae. Despite receiving active treatment, her condition rapidly deteriorated and she died 5 days later due to acute liver failure and multiple organ dysfunction. To the best of our knowledge, there are only six reported cases of liver injury associated with Fructus Psoraleae described in the English language literature; however, cases of acute liver failure associated with the use of Fructus Psoraleae have not been described. Conclusion As a main ingredient in the Qubaibabuqi tablet formula, Fructus Psoraleae has potential hepatotoxicity. This potentially fatal adverse effect should be considered when physicians prescribe Qubaibabuqi tablets.